The positive proportion of NK cells (CD49b+NKG2D+) was significantly higher than that observed in the other control groups, indicating a considerable expansion and activation of NK cells within the breast cancer tumor microenvironment (Figure 8d). The gene discussed is KLRK1; the disease is neoplasm.